Abstract
Objective The aim of this systematic review is to provide some evidence on the use of mobile phone communication for improving ARV adherence during pregnancy, as well as to investigate whether text messaging on mobile phones could improve follow-up in HIV-exposed infants.
Methods We did a systematic review and meta-analysis, using CENTRAL (Cochrane Central Register of Controlled Trials), Scopus, MEDLINE via PubMed, Web of Science, and CINAHL to search for studies in English published between 5 may 2016 to May 2021 that assessed the effects of mobile phone in HIV-infected pregnant women. We used MetaPro version 3.0 to compute the OR and RR and their 95%CI. We performed random-effects model meta-analysis for estimating pooled outcomes.
Results Nine studies were included in the meta-analysis. The pooled maternal post-partum retention was (OR 2.20, 95%CI: 1.55 – 3.13, I2 = 53.20%, P < 0.001).
In the same line, the pooled odds of ART uptake was (OR 1.5, 95%CI: 1.07-2.11, I2 =0%, P = 0.020) and we found statistically significant impact of mobile phone on HIV testing at 6 weeks and above among HIV exposed children (OR 1.89, 95%CI: 1.04 – 3. 48, I2 = OR 1.89, 95%CI: 1.04 – 3. 48, I2 =88.04%, P = 0.032).
Conclusion In comparison to our previous review, this updated review focuses on moderate evidence for mobile phone communication in HIV-infected pregnant women. The results showed that using a mobile phone improved maternal post-partum retention, ART uptake, and infant HIV testing at 6 weeks and older.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data are openly available and included as table of included studies.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in this present work are contained in the manuscript.
- Abbreviations
- ANC
- ante-natal consultation
- ART
- antiretroviral therapy
- CENTRAL
- Cochrane Central Register of Controlled Trials
- CRTs
- cluster randomized control trials
- EACS
- European AIDS Clinical Society
- eMTCT
- elimination of mother-to-child transmission
- HAART
- Highly active antiretroviral therapy
- HIV
- human immunodeficiency virus
- IAS
- International AIDS Society Conference on HIV Pathogenesis and Treatment
- IRTs
- individual randomized control trials
- MeSH
- Medical subject heading
- mHealth
- mobile health
- MMWR
- Morbidity and Mortality Weekly Report
- MTCT
- mother–to– child HIV transmission
- ORs
- Odds ratio
- PICOS
- Participants-Intervention-Comparisons-Outcomes-Settings
- PCR
- polymerase chain reaction
- PMTCT
- Prevention of mother-to-child transmission
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-analyses
- RR
- risk ratio
- SMS
- Short Message Service
- UNAIDS
- The Joint United Nations Programme on HIV/AIDS
- US
- United States
- WHO
- World Health Organization
